loading
Precedente Chiudi:
$7.00
Aprire:
$5.86
Volume 24 ore:
134.37K
Relative Volume:
3.08
Capitalizzazione di mercato:
$611.37M
Reddito:
$5.12M
Utile/perdita netta:
$-67.00M
Rapporto P/E:
-4.4966
EPS:
-1.47
Flusso di cassa netto:
$-38.94M
1 W Prestazione:
-19.02%
1M Prestazione:
+10.17%
6M Prestazione:
-8.55%
1 anno Prestazione:
-90.88%
Intervallo 1D:
Value
$5.86
$6.78
Intervallo di 1 settimana:
Value
$5.86
$8.16
Portata 52W:
Value
$3.816
$73.40

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
Nome
Verrica Pharmaceuticals Inc
Name
Telefono
484-453-3300
Name
Indirizzo
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
Dipendente
71
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
VRCA's Discussions on Twitter

Confronta VRCA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
6.61 64.74M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-06 Downgrade H.C. Wainwright Buy → Neutral
2024-11-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-07-25 Aggiornamento Needham Hold → Buy
2023-03-22 Iniziato Jefferies Buy
2023-02-13 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-05-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
2021-05-14 Iniziato RBC Capital Mkts Outperform
2020-12-24 Reiterato H.C. Wainwright Buy
2020-07-15 Downgrade BofA Securities Buy → Neutral
2020-06-30 Reiterato H.C. Wainwright Buy
2020-06-24 Iniziato Northland Capital Outperform
2020-03-24 Iniziato Needham Buy
2019-02-21 Iniziato H.C. Wainwright Buy
Mostra tutto

Verrica Pharmaceuticals Inc Borsa (VRCA) Ultime notizie

pulisher
Jul 25, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockExceptional return forecasts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Verrica Pharmaceuticals Inc. stock priceFree Stock Selection - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Verrica Pharmaceuticals Inc. stock overhyped or has real potentialFree Consultation - Newser

Jul 25, 2025
pulisher
Jul 24, 2025

VRCA Trading Halted: Anticipation Builds for Pending Announcemen - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Is Verrica Pharmaceuticals Inc. stock a good hedge against inflationRemarkably fast returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Verrica Pharmaceuticals Inc. a good long term investmentAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 07:38:47 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying Verrica Pharmaceuticals Inc. stock nowDaily Trade Opportunity - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharplyInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Verrica Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $8.00 Average Target Price from Brokerages - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates - MyChesCo

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Down 4.9% – Should You Sell? - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 | VRCA Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales - Investing.com

Jul 09, 2025
pulisher
Jul 02, 2025

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement - MyChesCo

Jul 02, 2025
pulisher
Jul 01, 2025

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Commo - GuruFocus

Jul 01, 2025

Verrica Pharmaceuticals Inc Azioni (VRCA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):